Volume 5 Supplement 9
Genetic Analysis Workshop 17: Unraveling Human Exome Data
Detection of associations with rare and common SNPs for quantitative traits: a nonparametric Bayes-based approach
- Lili Ding^{1, 2}Email author,
- Tesfaye M Baye^{2, 3},
- Hua He^{4},
- Xue Zhang^{4},
- Brad G Kurowski^{2, 5} and
- Lisa J Martin^{1, 2, 4}
DOI: 10.1186/1753-6561-5-S9-S10
© Ding et al; licensee BioMed Central Ltd. 2011
Published: 29 November 2011
Abstract
We propose a nonparametric Bayes-based clustering algorithm to detect associations with rare and common single-nucleotide polymorphisms (SNPs) for quantitative traits. Unlike current methods, our approach identifies associations with rare genetic variants at the variant level, not the gene level. In this method, we use a Dirichlet process prior for the distribution of SNP-specific regression coefficients, conduct hierarchical clustering with a distance measure derived from posterior pairwise probabilities of two SNPs having the same regression coefficient, and explore data-driven approaches to select the number of clusters. SNPs falling inside the largest cluster have relatively low or close to zero estimates of regression coefficients and are considered not associated with the trait. SNPs falling outside the largest cluster have relatively high estimates of regression coefficients and are considered potential risk variants. Using the data from the Genetic Analysis Workshop 17, we successfully detected associations with both rare and common SNPs for a quantitative trait. We conclude that our method provides a novel and broadly applicable strategy for obtaining association results with a reasonably low proportion of false discovery and that it can be routinely used in resequencing studies.
Background
The two highly debated hypotheses on the genetic basis of complex human diseases are the common disease/common variant (CDCV) hypothesis and the common disease/rare variant (CDRV) hypothesis [1]. The CDCV hypothesis states that common diseases are caused by common variants (minor allele frequencies [MAF] > 5%) with small to modest effects. The CDRV hypothesis, on the other hand, argues that common diseases are caused by multiple rare variants (MAF < 5%), each with moderate to high penetrance. Although both common and rare variants likely play a role in complex human diseases, most statistical strategies for association analysis have been developed under the CDCV assumption, except recent work by Li and Leal [2] and Han and Pan [3]. A key strategy for association analysis with rare variants is to study the cumulative effect of multiple rare variants within the same gene or linkage disequilibrium block [2, 4, 5]. However, these methods identify genetic risk factors at the gene level, not the variant level. We propose a nonparametric Bayes-based approach to detect associations with both rare and common genetic variants for quantitative traits. This approach clusters single-nucleotide polymorphisms (SNPs) according to the magnitude of SNP-specific regression coefficients. SNPs clustered together could come from different linkage disequilibrium blocks, genes, or even different chromosomes and could have quite different MAFs.
Methods
for i = 1, 2, …, n, where γ is a vector of regression coefficients, including the intercept and slopes for individual-specific covariates, the β_{ j } are the SNP-specific regression coefficients, and ε_{ i } is the error term. We specify the following prior distributions for the model parameters: , β_{ j } ~ G, G ~ DP(α, G_{0}), and σ ~ U(a, b). Here, v^{2} and b >a ≥ 0 are prespecified hyperparameters, is a (p + 1)-dimensional normal distribution with mean vector μ and variance-covariance matrix Σ, 0 is a vector of zeros, I is an identity matrix, G denotes a random distribution, U(a, b) denotes a uniform distribution between a and b, and DP(α, G_{0}) is the Dirichlet process.
Dirichlet process
The Dirichlet process [6] is a probability model on a space of probability distributions. It has two parameters: the base probability distribution G_{0} and the precision parameter α (>0). If G ~ DP(α, G_{0}), then G_{0} is the prior expectation of G and α controls the variance of G. Here, we take , which is a normal density truncated below at 0, and use U(c, d), d >c > 0, as the prior distribution for the precision parameter α.
is a random probability distribution generated from DP(α, G_{0}), where δ_{ ϕ }_{ k } denotes a point mass at ϕ_{ k }. It is clear that G is discrete with probability 1. Because of the discreteness, the β_{ j } can take on the same value. That is why the Dirichlet process can be used for clustering analysis.
Ishwaran and James [8] studied a truncated version of the Dirichlet process by choosing a truncation level N and setting V_{ N } = 1 in the stick-breaking construction. They used the truncated Dirichlet process to approximate Dirichlet process prior distributions and developed a block Gibbs sampling method for Dirichlet process models.
Clustering
Each iteration of the Gibbs sampler gives a clustering structure of SNP-specific regression coefficients such that coefficients taking the same value are clustered together. The number of clusters and the cluster membership of the coefficients vary across iterations, giving a random sample of clustering structures. Pairwise probabilities of two coefficients being equal are calculated from the posterior samples [9]. A distance measure is derived as 1 minus these pairwise probabilities and is then used in complete linkage hierarchical clustering to obtain a final clustering structure of the SNPs. We study a range of the number of clusters, from as small as 2–5 clusters to as large as 100 clusters. Optimal cluster numbers are also obtained by striking a balance between sensitivity and specificity. In all cases, SNPs in the largest cluster have relatively low or close to zero estimates of regression coefficients and are considered not associated with the trait. SNPs falling outside the largest cluster have relatively high estimates of regression coefficients and are considered potential risk variants. The proportion of false discovery (FDP), defined as the ratio of the number of false discoveries to the total number of discoveries, is examined.
Application of the method
We illustrate our methods using the data from Genetic Analysis Workshop 17. The analyses were performed with the knowledge of the underlying simulation model [10]. We studied the first 10 replicates of the quantitative trait Q1. Each replicate contains 697 unrelated individuals from 7 populations. To control for population stratification, we conducted principal components analysis on nonsynonymous common SNPs (n = 1,379) and included the resulting first two components as covariates, in addition to Age and Smoke. We built our model with 244 nonsynonymous SNPs selected from the vascular endothelial growth factor (VEGF) pathway [11]. These SNPs include all 39 functional SNPs for Q1, of which 23 are private variants (found in one individual, MAF = 0.000717) and 2 are common SNPs. The model was fitted using WinBUGS [12] with v^{2} = 1,000, a = 0, b = 100, c = 0.5, d = 20, µ_{0} = 0.5, and . The truncation level for the Dirichlet process was fixed at 50. For each replicate, 10,000 Markov chain Monte Carlo posterior samples were generated after a burn-in period of 2,000 iterations.
We evaluated our results using two thresholds. When the number of clusters was small (2–5), we defined true positives as true associations identified in at least 2 of the 10 replicates. This threshold was selected to balance the reduced power resulting from small cluster numbers. Indeed, requiring at least two replications for each identified association yielded a reasonably low FDP. When we used the optimal cluster numbers, we defined true positives as true associations detected in no less than eight replicates. We carried out sensitivity analyses on the prior specification for the SNP-specific regression coefficients with µ_{0} ranging from 0.1 to 0.5 and ranging from 0.5 to 2. Similar results were obtained.
Results and discussion
Successful identification of associations
True discoveries in at least two replicates with 2 to 5 clusters
Gene | SNP | MAF | β | F2 | F3 | F4 | F5 |
---|---|---|---|---|---|---|---|
FLT1 | C13S523 | 0.066714 | 0.64997 | 10 | 10 | 10 | 10 |
FLT1 | C13S431 | 0.017217 | 0.74136 | 9 | 9 | 9 | 9 |
FLT1 | C13S522 | 0.027977 | 0.61830 | 8 | 8 | 8 | 8 |
VEGFA | C6S2981 | 0.002152 | 1.20645 | 6 | 6 | 6 | 7 |
ARNT | C1S6533 | 0.011478 | 0.5619 | 5 | 6 | 7 | 7 |
FLT1 | C13S524 | 0.004304 | 0.62223 | 4 | 4 | 5 | 5 |
KDR | C4S1884 | 0.020803 | 0.29558 | 4 | 4 | 4 | 5 |
KDR | C4S1878 | 0.164993 | 0.13573 | 2 | 4 | 4 | 4 |
KDR | C4S1877 | 0.000717 | 1.07706 | 1 | 4 | 5 | 6 |
KDR | C4S1889 | 0.000717 | 0.94133 | 1 | 2 | 3 | 5 |
ARNT | C1S6542 | 0.002152 | 0.46026 | 1 | 2 | 2 | 2 |
KDR | C4S1861 | 0.002152 | 0.56311 | 1 | 1 | 1 | 2 |
Selection of optimal number of clusters
True discoveries in at least eight replicates with optimal cluster numbers
Gene | SNP | MAF | β |
---|---|---|---|
F = 10, TP = 10, FP = 2, FDP = 17% | |||
ARNT | C1S6561 | 0.000717 | 0.65721 |
KDR | C4S1877 | 0.000717 | 1.07706 |
KDR | C4S1879 | 0.000717 | 0.61830 |
KDR | C4S1889 | 0.000717 | 0.94133 |
VEGFC | C4S4935 | 0.000717 | 1.35726 |
VEGFA | C6S2981 | 0.002152 | 1.20645 |
FLT1 | C13S431 | 0.017217 | 0.74136 |
FLT1 | C13S522 | 0.027977 | 0.61830 |
FLT1 | C13S523 | 0.066714 | 0.64997 |
FLT1 | C13S524 | 0.004304 | 0.62223 |
F = 9, TP = 15, FP = 2, FDP = 12% | |||
ELAVL4 | C1S3181 | 0.000717 | 0.76911 |
ELAVL4 | C1S3182 | 0.000717 | 0.30432 |
ARNT | C1S6533 | 0.011478 | 0.56190 |
FLT1 | C13S399 | 0.000717 | 0.39602 |
FLT1 | C13S479 | 0.000717 | 0.75946 |
F = 8, TP = 19, FP = 4, FDP = 17% | |||
KDR | C4S1873 | 0.000717 | 0.58301 |
KDR | C4S1884 | 0.020803 | 0.29558 |
FLT4 | C5S5156 | 0.000717 | 0.43010 |
FLT1 | C13S505 | 0.000717 | 0.44850 |
We then evaluated the performance of this method using a specified number of clusters, ranging from 50 to 100. Using only associations identified with 100% power, we had 8 to 10 true positives and at most 2 false negatives (FDP ranging from 10% to 18%). For 90% power, we had 8 to 16 true positives and at most 4 false negatives (FDP ranging from 8% to 20%). Thus cluster numbers of 50 to 100 seem reasonable.
Characteristics of the true positives and false negatives
Conclusions
We have demonstrated that a novel nonparametric Bayes-based clustering method can be used to identify associations with SNPs for quantitative traits. Importantly, this method is capable of detecting associations with both rare and common genetic variants. Compared with other methods that deal with rare variants, our methods detect genetic risk factors directly at the SNP level. Compared with single-SNP-based methods, the proposed method is more powerful and reliable. It can detect a relatively larger proportion of true associations independent of the MAF of the variants, and it produces a relatively lower proportion of false discoveries.
Declarations
Acknowledgments
We wish to thank Siva Sivaganesan for valuable discussion and two anonymous reviewers for their insightful comments and suggestions. This work was supported by National Institutes of Health (NIH) grants K01 HL103165, K12 HD001097-14, K24 HL69712, R01 NS036695, and U19 A1070235. The Genetic Analysis Workshops are supported by NIH grant R01 GM031575 from the National Institute of General Medical Sciences.
This article has been published as part of BMC Proceedings Volume 5 Supplement 9, 2011: Genetic Analysis Workshop 17. The full contents of the supplement are available online at http://www.biomedcentral.com/1753-6561/5?issue=S9.
Authors’ Affiliations
References
- Schork NJ, Murray SS, Frazer KA, Topol EJ: Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev. 2009, 19: 212-219. 10.1016/j.gde.2009.04.010.PubMed CentralView ArticlePubMedGoogle Scholar
- Li B, Leal SM: Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. Am J Hum Genet. 2008, 83: 311-321. 10.1016/j.ajhg.2008.06.024.PubMed CentralView ArticlePubMedGoogle Scholar
- Han F, Pan W: A data-adaptive sum test for disease association with multiple common or rare variants. Hum Hered. 2010, 70: 42-54. 10.1159/000288704.PubMed CentralView ArticlePubMedGoogle Scholar
- Morgenthaler S, Thilly WG: A strategy to discover genes that carry multi-allelic or mono-allelic risk for common diseases: a cohort allelic sums test (CAST). Mutat Res Fund Mol Mech. 2007, 615: 28-56. 10.1016/j.mrfmmm.2006.09.003.View ArticleGoogle Scholar
- Madsen BE, Browning SR: A groupwise association test for rare mutations using a weighted sum statistic. PLoS Genet. 2009, 5: e1000384-10.1371/journal.pgen.1000384.PubMed CentralView ArticlePubMedGoogle Scholar
- Ferguson TS: Bayesian analysis of some nonparametric problems. Ann Stat. 1973, 1: 209-230. 10.1214/aos/1176342360.View ArticleGoogle Scholar
- Sethuraman J: A constructive definition of Dirichlet priors. Stat Sinica. 1994, 4: 639-650.Google Scholar
- Ishwaran H, James LF: Gibbs sampling methods for stick-breaking priors. J Am Stat Assoc. 2001, 96: 161-173. 10.1198/016214501750332758.View ArticleGoogle Scholar
- Medvedovic M, Sivaganesan S: Bayesian infinite mixture model based clustering of gene expression profiles. Bioinformatics. 2002, 18: 1194-1206. 10.1093/bioinformatics/18.9.1194.View ArticlePubMedGoogle Scholar
- Almasy LA, Dyer TD, Peralta JM, Kent JW, Charlesworth JC, Curran JE, Blangero J: Genetic Analysis Workshop 17 mini-exome simulation. BMC Proc. 2011, 5 (suppl 9): S2-10.1186/1753-6561-5-S9-S2.PubMed CentralView ArticlePubMedGoogle Scholar
- BioCarta: Pathways: VEGF, hypoxia, angiogenesis. [http://www.biocarta.com/pathfiles/h_vegfpathway.asp]
- Lunn DJ, Thomas A, Best N, Spiegelhalter D: WinBUGS: a Bayesian modeling framework—concepts, structure, and extensibility. Stat Comput. 2000, 10: 325-337. 10.1023/A:1008929526011.View ArticleGoogle Scholar
Copyright
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.